| Publications |
(Currently 512486 Items)
|
 |
| Partners |
|
|
|
| BIOTECHNOLOGY / Total: 9100 |
PREVIOUS | 1
| 2
| 3
| 4
| 5
| 6
| 7
| 8
| 9
| 10
| 11
| 12
|
NEXT 
|
| Title |
Date |
Price |
|
The MedicalCV Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
The Medicines Company Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
Health Insurance Plan of Greater New York (HIP), including its acquisition of Vytra Health Plans, with more than one million members is the largest HMO and one of the largest health plans in the New York... |
Apr, 2004 |
€369 |
|
The Medicis Pharmaceutical Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Medicure Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The MedImmune Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Medivation Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Mar, 2006 |
€375 |
|
The Memory Pharmaceuticals Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Merck & Co Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Meridian Bioscience Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Oct, 2006 |
€375 |
|
The Metabasis Therapeutics Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The MGI Pharma Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The microHelix Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Mar, 2006 |
€375 |
|
Cloning technology presents humanity with the very real possibility that it may, one day, control not only its destiny, but also its origin. Cloning allows man to fashion his own essential nature and turn... |
Feb, 2003 |
€535 |
|
Highmark, Inc. (Highmark) operates as a Pennsylvania nonprofit hospital plan and a nonprofit professional health service plan. As an independent licensee of the Blue Cross and Blue Shield Association (BCBSA),... |
Sep, 2005 |
€369 |
|
The MicroIslet Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The MicroMed Cardiovascular Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Oct, 2006 |
€375 |
|
The Migenix Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Millennium Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Minrad International Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
|
|
|
